A Risk Assessment Tool to Increase Statin Use Among High Risk Cancer Survivors: Development and Pilot Testing



Status:Active, not recruiting
Conditions:Cancer, Cancer
Therapuetic Areas:Oncology
Healthy:No
Age Range:25 - Any
Updated:9/8/2018
Start Date:August 2016
End Date:August 2019

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria
The purpose of this study is to collect initial data on what survivors of childhood,
adolescent, and young adult cancer think of how information about statins is communicated.
Statins are medications that lower cholesterol. The results of this study will be used to
improve the communication about statins. This is to aid patients and their providers in
making health care decisions together, also known as shared decision making.


Inclusion Criteria:

- English speaking

- A personal history of cancer, tumor, or a related illness

- Followed in the Adult Long Term Follow Up Program

- Received ≥ 2000 cGy radiation to the heart/chest

- ≥Ten years post-radiation therapy to the heart/chest

- Age ≥ 25 years old

Exclusion Criteria:

- Evidence of active progression of disease or recurrence

- Neurocognitive deficits that impair ability to give informed consent

- Current use of a statin

- Diagnosis of another primary cancer for which the patient is currently undergoing
radiation therapy chemotherapy, or bone marrow transplant

- Diagnosis of CVD with or without current statin use
We found this trial at
1
site
Memorial Sloan Kettering Cancer Center
1275 York Ave
New York, New York 10021
(212) 639-2000
Principal Investigator: Nirupa Raghunathan, MD
Memorial Sloan Kettering Cancer Center Memorial Sloan Kettering Cancer Center — the world's oldest and...
?
mi
from
New York, NY
Click here to add this to my saved trials